I was praising the PR up until today. Really not well written and a glaring “if” ... no “if” or vague statements tomorrow Joe! The upside, and maybe the reality, is that China is not going to pay $2m to not run trials ... and it seems like they just stole our IP for the purposes of China. But what can we do ... out of money and out of time and that’s the price of doing business in China ...
Generex Biotechnology Corp. (GNBT) Stock Research Links